Large Area Opioid Identification by Bioengineered Broad-Spectrum Receptors
Award amount
$167,497Program and phase
STTR · Phase IAward year
2021Award details
- Awarding agency
- Department of Defense
- Branch
- Office for Chemical and Biological Defense
- Recipient company
- ZYMERON CORPORATION
- Proposal award date
- 2021-01-08
- Contract end date
- 2021-06-10
- UEI
- GAMMMRQ6QMN1
- Solicitation number
- 20.A
- Topic code
- CBD20A-T001
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- An Automated Blood-in, miRNAs-out Assay to Detect Circulating and Exosome miRNAs
- Development of WoundShield for Pseudomonas aeruginosa-Caused Wounds Infections
- Omnidetect: a multiplexed portable detection platform enables culture-free enrichment and amplification to detect all types of foodborne pathogens
- Rapid Sample Processing Device to Support Battlefield Wound Infection Diagnostics
- Advanced portable low temperature plasma device for chronic wound disinfection and healing
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Eye-readable Solution-based Dye Displacement Probe for Large-area Detection of Opioids
- Opioid Indicator Spray for Complex Surfaces
- Spray-based visual indicator of opioids for the rapid and effective decontamination of large areas
Research funding history
42 SBIR/STTR records share this UEI (2017–2024). Reported award amounts total $24,710,238. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Health and Human Services, Department of Energy